Table 6.
Summary of device study objectives (intermittent recording devices).
Device, study, heart disorder or ECGa abnormality | Comparators | Participants, n | Sensitivity, % | Specificity, % | Accuracy, % | ||||||||
Handheld | |||||||||||||
|
Beurer ME 80 | ||||||||||||
|
|
Nigolian et al [23] | |||||||||||
|
|
|
AFb | 12-lead device | 16 | 100 | 94 | 96 | |||||
|
|
|
AVBc | 12-lead device | 13 | 85 | 97 | 94 | |||||
|
|
|
LBBBd | 12-lead device | 7 | 71 | 100 | 96 | |||||
|
|
|
RBBBe | 12-lead device | 10 | 90 | 100 | 98 | |||||
|
|
|
LVHf | 12-lead device | 5 | 80 | 100 | 98 | |||||
|
|
|
ST-segment elevation | 12-lead device | 11 | 64 | 93 | 87 | |||||
|
|
|
ST-segment depression | 12-lead device | 13 | 54 | 95 | 85 | |||||
|
|
|
Prolonged QTc | 12-lead device | 4 | 50 | 91 | 88 | |||||
|
Coala Heart Monitor | ||||||||||||
|
|
Insulander et al [24] | |||||||||||
|
|
|
AF | —g | 1000 | 95.1 | 97.6 | 97.3 | |||||
|
ECG Check | ||||||||||||
|
|
Aljuaid et al [25] | |||||||||||
|
|
|
AF | Holter | 90 | 100 | 97 | — | |||||
|
Eko DUO | ||||||||||||
|
|
Bokma et al [26] | |||||||||||
|
|
|
CHDh | 12-lead device, Move ECG, KardiaMobile | 176 | 100 | 99 | — | |||||
|
|
Bachtiger et al [27] | |||||||||||
|
|
|
LVEFi of ≤40% | 12-lead device | 1050 | 91.9 | 80.2 | — | |||||
|
Istel HR-2000 | ||||||||||||
|
|
Krzowski et al [28] | |||||||||||
|
|
|
Sinus rhythm | 12-lead device and KardiaMobile | 98 | 91.5 | 84.6 | — | |||||
|
|
|
AF | 12-lead device and KardiaMobile | 98 | 77.3 | 98.7 | — | |||||
|
KardiaMobile | ||||||||||||
|
|
Krzowski et al [28] | |||||||||||
|
|
|
Sinus rhythm | 12-lead device and Istel HR-2000 | 98 | 88.1 | 89.7 | — | |||||
|
|
|
AF | 12-lead device and Istel HR-2000 | 98 | 86.4 | 97.4 | — | |||||
|
|
Palà et al [29] | |||||||||||
|
|
|
AF | WatchBP, MyDiagnostick, and FibriCheck | 359 | 80 | 95.5 | — | |||||
|
|
Lau et al [30] | |||||||||||
|
|
|
AF | 12-lead device | 109 | 97.5 | 92 | 94.5 | |||||
|
|
Desteghe et al [31] | |||||||||||
|
|
|
AF (cardiology ward) | 12-lead device and MyDiagnostick | 445 | 54.5 | 97.5 | — | |||||
|
|
|
AF (geriatric ward) | 12-lead device and MyDiagnostick | 445 | 78.9 | 97.9 | — | |||||
|
|
Bokma et al [26] | |||||||||||
|
|
|
CHD | 12-lead device, Move ECG, and Eko DUO | 176 | 100 | 99 | — | |||||
|
|
Scholten et al [32] | |||||||||||
|
|
|
AF | 12-lead device, Apple Watch, and Move ECG | 220 | 99 | 97 | — | |||||
|
|
Bumgarner et al [33] | |||||||||||
|
|
|
AF | 12-lead device | 100 | 99 | 83 | — | |||||
|
|
Ford et al [34] | |||||||||||
|
|
|
AF | Apple Watch | 125 | 94 | 90 | 91 | |||||
|
|
Wasserlauf et al [35] | |||||||||||
|
|
|
AF | Implantable Cardiac Monitor | 24 | 83.3 | 83.3 | — | |||||
|
|
Himmelreich et al [36] | |||||||||||
|
|
|
AF and AFLj | 12-lead device | 23 | 100 | 100 | — | |||||
|
|
|
AF | 12-lead device | 44 | 90.9 | 93.5 | — | |||||
|
|
|
AF | 12-lead device | 28 | 46.4 | 100 | — | |||||
|
MyDiagnostick | ||||||||||||
|
|
Tieleman et al [37] | |||||||||||
|
|
|
AF | 12-lead device | 192 | 100 | 95.9 | — | |||||
|
|
Palà et al [29] | |||||||||||
|
|
|
AF | WatchBP, KardiaMobile, and FibriCheck | 359 | 76.9 | 97.1 | — | |||||
|
|
Verbiest-van Gurp et al [38] | |||||||||||
|
|
|
AF | 12-lead device and WatchBP | 4339 | 90.1 | 97.9 | — | |||||
|
|
Vaes et al [39] | |||||||||||
|
|
|
AF | 12-lead device | 191 | 94 | 93 | — | |||||
|
|
Yeo et al [40] | |||||||||||
|
|
|
AF | 12-lead device | 671 | 100 | 96.2 | — | |||||
|
|
Karregat et al [41] | |||||||||||
|
|
|
Paroxysmal AF | 12-lead Holter | 270 | 66.7 | 68.8 | — | |||||
|
|
Desteghe et al [31] | |||||||||||
|
|
|
AF (cardiology ward) | 12-lead device and KardiaMobile | 445 | 81.8 | 94.2 | — | |||||
|
|
|
AF (geriatric ward) | 12-lead device and KardiaMobile | 445 | 89.5 | 95.7 | — | |||||
|
Zenicor-ECG | ||||||||||||
|
|
Doliwa et al [42] | |||||||||||
|
|
|
AF | 12-lead device | 49 | 96 | 92 | — | |||||
Wearable | |||||||||||||
|
Apple Watch | ||||||||||||
|
|
Abu-Alrub et al [43] | |||||||||||
|
|
|
AF | Galaxy Watch Active 3, and Move ECG | 100 | 87 | 86 | — | |||||
|
|
Nasarre et al [44] | |||||||||||
|
|
|
Cardiac abnormalities and cardiac arrest | 12-lead device | 67 | 100 | 100 | — | |||||
|
|
|
Brugada Syndrome | 12-lead device | 67 | 92 | 100 | — | |||||
|
|
|
Long QT | 12-lead device | 67 | 80 | 100 | — | |||||
|
|
|
HCMk | 12-lead device | 67 | 92 | 85 | — | |||||
|
|
|
ARVC/Dl | 12-lead device | 67 | 100 | 99 | — | |||||
|
|
Caillol et al [45] | |||||||||||
|
|
|
Bradyarrhythmias | 12-lead device | 40 | 96 | 91 | — | |||||
|
|
|
Tachyarrhythmias | 12-lead device | 40 | 25 | 99 | — | |||||
|
|
|
Cardiac Ischemia | 12-lead device | 40 | 7 | 100 | — | |||||
|
|
Spaccarotella et al [46] | |||||||||||
|
|
|
Measurements of the QT interval | 12-lead device | — | 69 | 88 | — | |||||
|
|
Scholten et al [32] | |||||||||||
|
|
|
AF | 12-lead device, Move ECG, and KardiaMobile | 220 | 96 | 94 | — | |||||
|
|
Ford et al [34] | |||||||||||
|
|
|
AF | KardiaMobile | 125 | 68 | 93 | 87 | |||||
|
Move ECG | ||||||||||||
|
|
Bokma et al [26] | |||||||||||
|
|
|
CHD | 12-lead device, KardiaMobile, and Eko DUO | 176 | 100 | 98 | — | |||||
|
Abu-Alrub et al [43] | ||||||||||||
|
|
AF | Apple Watch, Galaxy Watch Active 3 | 100 | 88 | 81 | — | ||||||
|
Scholten et al [32] | ||||||||||||
|
|
AF | 12-lead device, Apple Watch, and KardiaMobile | 220 | 95 | 95 | — | ||||||
|
Nuubo ECG Vest | ||||||||||||
|
|
Eysenck et al [16] | |||||||||||
|
|
|
AF | Zio XT, Nuubo ECG Vest, BardyDX CAM, and R.Test Evolution 4 | 21 | — | — | 30-second recording: 97; 6-minute recording: 89.7 | |||||
|
Fitbit | ||||||||||||
|
|
Rajagopalan [47] | |||||||||||
|
|
|
AF | 12-lead device | 475 | 98.7 | 100 | — | |||||
|
Galaxy Active Watch | ||||||||||||
|
|
Yang [48] | |||||||||||
|
|
|
AF | 12-lead device | 544 | 98.1 | 100 | — |
aECG: electrocardiogram.
bAF: atrial fibrillation.
cAVB: atrioventricular block.
dLBBB: left bundle branch block.
eRBBB: right bundle branch block.
fLVH: left ventricular hypertrophy.
gNot available.
hCHD: congenital heart defect.
iLVEF: low ventricular ejection fraction.
jAFL: atrial flutter.
kHCM: hypertrophic cardiomyopathy.
lARVC/D: arrhythmogenic right ventricular cardiomyopathy/dysplasia.